Last-Minute Drug Bill Rewrite Wins Votes

By Emily Pierce
Roll Call Staff

April 12, 2007, 12 a.m.

Senate Finance Chairman Max Baucus (D-Mont.) is on the brink of garnering a filibuster-proof majority for his measure designed to lower Medicare drug prices, even as one of the original sponsors of the bill threatens to unravel a delicate bipartisan coalition.

Most Popular
Most E-Mailed

The Costs of the Cap-and-Trade Bill
Defense: 10 Staffers to Know
Waxman Being Discharged From Hospital

The Costs of the Cap-and-Trade Bill
What Should Dental Health Care Look Like in a Reformed Health System?
Congress Must Create Some Entrepreneurial Opportunities in Crisis

Commitee Insider
Policy Briefings
Mission Ahead
The Chief

Stier: Detecting a Bad Breast Cancer Bill

July 1, 11:28 a.m.

Who could blame hundreds of Members of Congress for joining with a colleague and breast cancer survivor, Rep. Debbie Wasserman Schultz (D-Fla.), in co-sponsoring legislation aimed at promoting breast cancer education? The problem, according to leading breast cancer scientists and advocacy groups, is the bill would do more harm than good. Read Full Article